In the acute care environment, reducing the time to make an accurate diagnosis is a critical need. The Edge II features DirectClear Technology, a novel, patent-pending process that is available on select transducers. DirectClear elevates transducer performance by increasing penetration and contrast resolution. This contributes to an unsurpassed imaging experience for the bedside clinician.